The BCW Index has started the second half of 2006 strongly with a gain of 3.4 percent for the shortened trading week ended Monday. The Nasdaq Biotech Index outpaced the BCW Index, climbing 5.2 percent, while the Nasdaq gained 4.3 percent, and the Dow Jones Industrial Average rose 2.8 percent. Every stock in the Index gained ground for the tracking period, with Stratagene leading the way with a rise of 12.7 percent. Qiagen and Fisher Scientific both rose more than 6 percent for the week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.